Investors need to pay close attention to ACH stock based on the movements in the options market lately.
Accendra Health, Inc. is undergoing a multiyear turnaround, focusing on at-home medicine after divesting its hospital supply unit and cleaning up its balance sheet. ACH's recent refinancing extends maturities, reduces gross debt by ~$100 million, and provides a liquidity runway, enhancing the probability of successful long-term deleveraging. Management reaffirmed full-year guidance, but ongoing margin pressure and slow volume growth mean EBITDA will likely be at the lower end of the outlook.
Investors need to pay close attention to Accendra Health stock based on the movements in the options market lately.
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Edward A. Pesicka CEO | XFRA Exchange | 690732102 CUSIP |
| US Country | 6,500 Employees | 31 Dec 2021 Last Dividend | 1 Apr 2010 Last Split | 16 Dec 1988 IPO Date |
Owens & Minor, Inc., established in 1882 with its headquarters in Richmond, Virginia, is a global healthcare solutions company that operates through its subsidiaries. The company is structured around two main segments: Products & Healthcare Services, and Patient Direct. Targeting healthcare providers and manufacturers, Owens & Minor delivers a comprehensive array of products and services designed to meet the evolving needs of the healthcare industry. By serving a diverse clientele that includes multi-facility healthcare provider networks, independent hospitals, surgery centers, physicians' practices, and through third-party distributors, Owens & Minor positions itself as an integral part of the healthcare supply chain.
Owens & Minor offers a wide range of products and services tailored to the healthcare industry, under the following key categories: